Contact Us 

Office of Clinical Research
plauto@lsuhsc.edu

Section of Pulmonary & Critical Care Medicine
1901 Perdido Street
Suite 3205
New Orleans, LA  70112

2013 2:42:43 PM

ALA walk resized

Marie1

staff

Pulmonary Clinical Research

The LSUHSC Pulmonary Clinical Research Center is dedicated to conducting quality, meaningful clinical research that advances the knowledge, treatment, and understanding diseases of the lung.

Volunteering for participation in research studies is a generous act that creates the potential for obtaining new insights into treatments. This may eventually lead to improved diagnostic tests and therapies.

What are the benefits to participating in a research study?

  • Play an active role in your own health care
  • Gain access to new research treatments before they are widely available
  • Obtain expert medical care and medication during the trial at no cost
  • Help others by contributing to research
  • Education regarding your disease management

For more detailed information on any clinical trial listed below, search www.clinicaltrials.gov and enter the NCT number provided  below:

COPD:

BLOCK:  Beta-blockers for the prevention of Acute Exacerbations of COPD (NCT 02587351)

For information on our COPD research opportunities, contact Connie Romaine, APRN, FNP-C at 504-568-3452

Pulmonary Arterial Hypertension (PAH)

For information on our Pulmonary Hypertension research opportunities, contact Paula Lauto, RN, BSN at 504-568-3451

Pulmonary Hypertension Registries:

U.S. CTEPH Registry :   NCT 02429284 

SPHERE:   Uptravi® Selexipag: The Users Drug Registry:  NCT 03278002

OPUS:   U.S. Based, Observational Drug Registry of Opsumit® (macitentan): New Users in Clinical Practice: NCT 02126943

 

Pulmonary Hypertension Clinical Trials:

INCREASE :  A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Tiral to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease (United Therapeutics, Corp); NCT 02630316

TRITON:     The Efficacy and Safety of Initial Triple vs Initial Dual Oral Combination Therapy in Patients with Newly Diagnosed Pulmonary Arterial Hypertension:  A Multi-Center, Double-Blind, Placebo-Controlled, Phase 3b Study (Actelion Pharmaceuticals); NCT 02558231
 

For more information, please download any of our Research Study Brochures below:

Like us on Facebook!

2013 10:37:15 AM